Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration

Common pathogenic aspects of age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG), i.e., the role of free radicals inducing oxidative damage of the retina and optic nerve, are discussed. Factors that activate free radical reactions as well as multilevel antioxidant protectio...

Full description

Bibliographic Details
Main Author: K. A. Mirzabekova
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2015-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/204
_version_ 1797875554870886400
author K. A. Mirzabekova
author_facet K. A. Mirzabekova
author_sort K. A. Mirzabekova
collection DOAJ
description Common pathogenic aspects of age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG), i.e., the role of free radicals inducing oxidative damage of the retina and optic nerve, are discussed. Factors that activate free radical reactions as well as multilevel antioxidant protection system are reviewed. Data derived from studies on current antioxidants that are used to treat and prevent dry AMD and glaucomatous optic nerve damage are compared. Neuroprotection for glaucoma will be considered soon as a basis for its treatment. B vitamins are generally included into therapeutic algorithms for glaucomatous optic neuropathy. While being metabolic therapeutics, they stimulate adaptive compensatory mechanisms and reduce the severity of various pathological processes, e.g., hypoxia, lipid peroxidation etc. Neurotrophic, antioxidant, and regenerative effects of B vitamins as wells as their involvement in metabolism, myelinsynthesis and other processes are of special importance for ophthalmologists. Currently, several vitamin and mineral supplements that differ in composition, dosage, and schedule are approved in Russia. SuperOptic, a biologically activeadditive, contains more free lutein (10 mg) and zeaxanthin (500 μg) as well as potent antioxidants (vitamin E and vitamin C), microelements (zinc and copper), and balanced vitamin B complex. These components play an important role in ocular health. SuperOptic can be recommended for the prevention and treatment of AMD and glaucomatous optic nerve damage.
first_indexed 2024-04-10T01:49:23Z
format Article
id doaj.art-e93f34550111483d8333f69ea1706d38
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2024-04-10T01:49:23Z
publishDate 2015-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-e93f34550111483d8333f69ea1706d382023-03-13T09:08:36ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452015-01-01114414610.18008/1816-5095-2014-4-791-804202Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degenerationK. A. Mirzabekova0Федеральное государственное бюджетное учреждение Научно-исследовательский институт глазных болезней РАМН , Россолимо, д.11A,Б, 119021, Москва, Российская ФедерацияCommon pathogenic aspects of age-related macular degeneration (AMD) and primary open-angle glaucoma (POAG), i.e., the role of free radicals inducing oxidative damage of the retina and optic nerve, are discussed. Factors that activate free radical reactions as well as multilevel antioxidant protection system are reviewed. Data derived from studies on current antioxidants that are used to treat and prevent dry AMD and glaucomatous optic nerve damage are compared. Neuroprotection for glaucoma will be considered soon as a basis for its treatment. B vitamins are generally included into therapeutic algorithms for glaucomatous optic neuropathy. While being metabolic therapeutics, they stimulate adaptive compensatory mechanisms and reduce the severity of various pathological processes, e.g., hypoxia, lipid peroxidation etc. Neurotrophic, antioxidant, and regenerative effects of B vitamins as wells as their involvement in metabolism, myelinsynthesis and other processes are of special importance for ophthalmologists. Currently, several vitamin and mineral supplements that differ in composition, dosage, and schedule are approved in Russia. SuperOptic, a biologically activeadditive, contains more free lutein (10 mg) and zeaxanthin (500 μg) as well as potent antioxidants (vitamin E and vitamin C), microelements (zinc and copper), and balanced vitamin B complex. These components play an important role in ocular health. SuperOptic can be recommended for the prevention and treatment of AMD and glaucomatous optic nerve damage.https://www.ophthalmojournal.com/opht/article/view/204вмдантиоксидантылютеинзеаксантинокислительный стрессглаукома
spellingShingle K. A. Mirzabekova
Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
Oftalʹmologiâ
вмд
антиоксиданты
лютеин
зеаксантин
окислительный стресс
глаукома
title Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
title_full Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
title_fullStr Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
title_full_unstemmed Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
title_short Novel therapeutic approaches to correct retinal metabolic abnormalities in primary open-angle glaucoma and age-related macular degeneration
title_sort novel therapeutic approaches to correct retinal metabolic abnormalities in primary open angle glaucoma and age related macular degeneration
topic вмд
антиоксиданты
лютеин
зеаксантин
окислительный стресс
глаукома
url https://www.ophthalmojournal.com/opht/article/view/204
work_keys_str_mv AT kamirzabekova noveltherapeuticapproachestocorrectretinalmetabolicabnormalitiesinprimaryopenangleglaucomaandagerelatedmaculardegeneration